The DOI matches its Crossref record; 559 of the 559 references it cites were found in a registry or an index.
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Abstract
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major cause of disability worldwide. This neurological condition is commonly associated with neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), and has a significant impact on the increasing burden of these neuropathologies. Over the past decades, some of the pathophysiological and molecular mechanisms that contribute to these diseases have been elucidated and these findings indicate that, despite presenting distinct features, there are several similarities between the neurobiological alterations that lead to MDD and neurodegeneration in AD, PD, and HD. For instance, disturbances in monoaminergic transmission and the hypothalamic-pituitary-adrenal (HPA) axis, increased oxidative and neuroinflammatory events, and impaired trophic support are thought to contribute to neuronal atrophy and death in all these diseases. In addition, neuroimaging findings have helped elucidate the structural and functional changes implicated in the relationship between depression and neurodegeneration, thus establishing a neuroanatomical signature to explain, at least in part, the comorbidity between MDD and AD, PD, and HD. The present review summarizes these findings and the current evidence regarding the effectiveness of common antidepressant therapies for the treatment of MDD in patients with these neurodegenerative diseases. This population is particularly vulnerable to the drawdowns of conventional antidepressant therapy (namely inadequate response and high risk of side effects), and the development of emerging therapeutic approaches to treat MDD in patients with AD, PD, and HD is thus of paramount importance to improve the quality of life of these individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 559
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
van Duijn, E., Craufurd, D., Hubers, A. A. M., Giltay, E. J., Bonelli, R., Rickards, H., Anderson, K. E., van Walsem, M. R., van der Mast, R. C., Orth, M., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307343 · Cited by 299
Sinn, N., Milte, C. M., Street, S. J., Buckley, J. D., Coates, A. M., Petkov, J., & Howe, P. R. C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004788 · Cited by 297
Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.37 · Cited by 296
Depressive-like behavior induced by tumor necrosis factor-α in mice
Kaster, M. P., Gadotti, V. M., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.018 · Cited by 294
Self-citationLaakso, M. P., Soininen, H., Partanen, K., Helkala, E. L., Hartikainen, P., Vainio, P., Hallikainen, M., Hänninen, T., & Riekkinen Sr, P. J. (1995) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252964 · Cited by 292
Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease
Pahwa, R., Stacy, M. A., Factor, S. A., Lyons, K. E., Stocchi, F., Hersh, B. P., Elmer, L. W., Truong, D. D., & Earl, N. L. (2007) · Neurology · doi:10.1212/01.wnl.0000258660.74391.c1 · Cited by 290
Monoaminergic neuropathology in Alzheimer’s disease
Šimić, G., Babić Leko, M., Wray, S., Harrington, C. R., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., de Silva, R., Di Giovanni, G., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 289
The neurobiology of depression
Palazidou, E. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds004 · Cited by 288
Zheng, H., Lenard, N. R., Shin, A. C., & Berthoud, H.-R. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.65 · Cited by 285
Nelson, J. C., & Devanand, D. P. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03355.x · Cited by 284
Prevalence, Clinical Manifestations, Etiology, and Treatment of Depression in Parkinson's Disease
Slaughter, J. R., Slaughter, K. A., Nichols, D., Holmes, S. E., & Martens, M. P. (2001) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13.2.187 · Cited by 284
Dysfunction of NMDA receptors in Alzheimer’s disease
Zhang, Y., Li, P., Feng, J., & Wu, M. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2546-5 · Cited by 282
Maillet, A., Krack, P., Lhommée, E., Météreau, E., Klinger, H., Favre, E., Le Bars, D., Schmitt, E., Bichon, A., Pelissier, P., et al. (2016) · Brain · doi:10.1093/brain/aww162 · Cited by 282
Taylor, T. N., Caudle, W. M., Shepherd, K. R., Noorian, A., Jackson, C. R., Iuvone, P. M., Weinshenker, D., Greene, J. G., & Miller, G. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1495-09.2009 · Cited by 277
Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice
Callahan, M. J., Lipinski, W. J., Bian, F., Durham, R. A., Pack, A., & Walker, L. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64064-3 · Cited by 274
Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R., & Defebvre, L. (2008) · Movement Disorders · doi:10.1002/mds.21966 · Cited by 274
Carroll, J. C., Rosario, E. R., Kreimer, S., Villamagna, A., Gentzschein, E., Stanczyk, F. Z., & Pike, C. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.009 · Cited by 273
Leranth, C., Roth, R. H., Elsworth, J. D., Naftolin, F., Horvath, T. L., & Redmond, D. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08604.2000 · Cited by 271
Orexin loss in Huntington's disease
Petersén, Å., Gil, J., Maat-Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R., Popovic, N., Wierup, N., Norlén, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi004 · Cited by 271
Depression and Stages of Huntington's Disease
Paulsen, J. S. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.4.496 · Cited by 267
THOMPSON, P. D., BERARDELLI, A., ROTHWELL, J. C., DAY, B. L., DICK, J. P. R., BENECKE, R., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.223 · Cited by 263
Motor effects of serotonin in the central nervous system
Gerson, S. C., & Baldessarini, R. J. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90368-9 · Cited by 263
Simmons, D. A., Rex, C. S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C. M., & Lynch, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811228106 · Cited by 261
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Gerhard, D. M., Wohleb, E. S., & Duman, R. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.016 · Cited by 261
Cognitive and behavioural effects of music-based exercises in patients with dementia
Van de Winckel, A., Feys, H., De Weerdt, W., & Dom, R. (2004) · Clinical Rehabilitation · doi:10.1191/0269215504cr750oa · Cited by 257
Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5465-z · Cited by 256
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255
Rektorová, I., Rektor, I., Bareš, M., Dostál, V., Ehler, E., Fanfrdlová, Z., Fiedler, J., Klajblová, H., Kulišt’ák, P., Ressner, P., et al. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00612.x · Cited by 253
Santiago, R. M., Barbieiro, J., Lima, M. M. S., Dombrowski, P. A., Andreatini, R., & Vital, M. A. B. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.004 · Cited by 252
Carroll, J. C., Iba, M., Bangasser, D. A., Valentino, R. J., James, M. J., Brunden, K. R., Lee, V. M.-Y., & Trojanowski, J. Q. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-11.2011 · Cited by 251
Suri, D., & Vaidya, V. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.065 · Cited by 250
Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women
Manly, J. J., Merchant, C. A., Jacobs, D. M., Small, S. A., Bell, K., Ferin, M., & Mayeux, R. (2000) · Neurology · doi:10.1212/wnl.54.4.833 · Cited by 246
Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T., & Pimplikar, S. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907652106 · Cited by 245
Okamura, F., Tashiro, A., Utumi, A., Imai, T., Suchi, T., Tamura, D., Sato, Y., Suzuki, S., & Hongo, M. (2000) · Metabolism · doi:10.1053/meta.2000.9515 · Cited by 241
Ginovart, N. (1997) · Brain · doi:10.1093/brain/120.3.503 · Cited by 241
Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047387 · Cited by 236
Sex, trauma, stress hormones and depression
Young, E., & Korszun, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.94 · Cited by 235
Effects of gender on nigral gene expression and parkinson disease
Cantuti-Castelvetri, I., Keller-McGandy, C., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 234
Differences in duration of Huntington's disease based on age at onset
Foroud, T., Gray, J., Ivashina, J., & Conneally, P. M. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.52 · Cited by 234
Banerjee, S., Hellier, J., Romeo, R., Dewey, M., Knapp, M., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17070 · Cited by 233
Impaired Synaptic Plasticity in Mice Carrying the Huntington's Disease Mutation
Usdin, M. T., Shelbourne, P. F., Myers, R. M., & Madison, D. V. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.839 · Cited by 230
Fregni, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.027060 · Cited by 226
Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies
Postuma, R. B., Gagnon, J., Pelletier, A., & Montplaisir, J. (2013) · Movement Disorders · doi:10.1002/mds.25445 · Cited by 226
Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems
Gądek-Michalska, A., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71527-5 · Cited by 225
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial
Schenkman, M., Hall, D. A., Barón, A. E., Schwartz, R. S., Mettler, P., & Kohrt, W. M. (2012) · Physical Therapy · doi:10.2522/ptj.20110472 · Cited by 224
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
Rosenblatt, A., & Leroi, I. (2000) · Psychosomatics · doi:10.1016/s0033-3182(00)71170-4 · Cited by 223
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., De Miguel, Z., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 221
The association of affective disorder with Huntington's Disease in a case series and in families
Folstein, S. E., Abbott, M. H., Chase, G. A., Jensen, B. A., & Folstein, M. F. (1983) · Psychological Medicine · doi:10.1017/s0033291700047966 · Cited by 220
Psychiatric disorders in preclinical Huntington's disease
Julien, C. L., Thompson, J. C., Wild, S., Yardumian, P., Snowden, J. S., Turner, G., & Craufurd, D. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103309 · Cited by 219
Glucocorticoid and Mineralocorticoid Receptor mRNA Expression in Rat Brain
Chao, H. M., Choo, P. H., & McEwen, B. S. (1989) · Neuroendocrinology · doi:10.1159/000125250 · Cited by 216
The genetic landscape of Parkinson's disease
Lunati, A., Lesage, S., & Brice, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.004 · Cited by 215
Antidepressants for treating depression in dementia
Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214
Duman, R. S. (2014) · Depression and Anxiety · doi:10.1002/da.22227 · Cited by 213
Longitudinal Evaluation of Neuropsychiatric Symptoms in Huntington's Disease
Thompson, J. C., Harris, J., Sollom, A. C., Stopford, C. L., Howard, E., Snowden, J. S., & Craufurd, D. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11030057 · Cited by 211
Depression and subsequent risk of Parkinson disease: A nationwide cohort study
Gustafsson, H., Nordström, A., & Nordström, P. (2015) · Neurology · doi:10.1212/wnl.0000000000001684 · Cited by 211
Sairanen, M., O’Leary, O. F., Knuuttila, J. E., & Castrén, E. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.069 · Cited by 206
Du, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 205
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
Laakso, A., Vilkman, H., Bergman, J. Ö., Haaparanta, M., Solin, O., Syvälahti, E., Salokangas, R. K. R., & Hietala, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01369-0 · Cited by 203
The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
Pittenger, C., Sanacora, G., & Krystal, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363267 · Cited by 203
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
Pal, E., Nagy, F., Aschermann, Z., Balazs, E., & Kovacs, N. (2010) · Movement Disorders · doi:10.1002/mds.23270 · Cited by 199
Stress and trauma: BDNF control of dendritic-spine formation and regression
Bennett, M. R., & Lagopoulos, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.005 · Cited by 199
Brain-gut-microbiota axis: challenges for translation in psychiatry
Kelly, J. R., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.02.008 · Cited by 198
Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease
Mayberg, H. S., Starkstein, S. E., Peyser, C. E., Brandt, J., Dannals, R. F., & Folstein, S. E. (1992) · Neurology · doi:10.1212/wnl.42.9.1791 · Cited by 196
Stress Impairs LTP and Hippocampal‐Dependent Memorya
DIAMOND, D. M., & ROSE, G. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39271.x · Cited by 195
Balu, D. T., Hoshaw, B. A., Malberg, J. E., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.023 · Cited by 194
The selective vulnerability of brainstem nuclei to Alzheimer's disease
Parvizi, J., Van Hoesen, G. W., & Damasio, A. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<53::aid-ana30>3.0.co;2-q · Cited by 193
Age-Related Testosterone Depletion and the Development of Alzheimer Disease
Rosario, E. R. (2004) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.292.12.1431-b · Cited by 193
Pang, T. Y. C., Du, X., Zajac, M. S., Howard, M. L., & Hannan, A. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn385 · Cited by 188
Exercise training for depressed older adults with Alzheimer's disease
Williams, C. L., & Tappen, R. M. (2008) · Aging & Mental Health · doi:10.1080/13607860701529932 · Cited by 187
Song, C., Shieh, C.-H., Wu, Y.-S., Kalueff, A., Gaikwad, S., & Su, K.-P. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.003 · Cited by 187
Handbook of Depression in Adolescents
(2008) · Routledge eBooks · doi:10.4324/9780203809518 · Cited by 185
Socio-Psychiatric Consequences of Huntington's Disease
Dewhurst, K., Oliver, J. E., & McKnight, A. L. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.116.532.255 · Cited by 185
Carvalho, M. M., Campos, F. L., Coimbra, B., Pêgo, J. M., Rodrigues, C., Lima, R., Rodrigues, A. J., Sousa, N., & Salgado, A. J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-14 · Cited by 184
Self-citationSertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
Weintraub, D., Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Porsteinsson, A. P., Schneider, L. S., Munro, C. A., Meinert, C. L., Lyketsos, C. G., et al. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181cc0333 · Cited by 183
Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies
Wen, M. ‐., Chan, L. L., Tan, L. C. S., & Tan, E. K. (2016) · European Journal of Neurology · doi:10.1111/ene.13002 · Cited by 183
Neuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182
Cognitive disorders and neurogenesis deficits in Huntington’s disease mice are rescued by fluoxetine
Grote, H. E., Bull, N. D., Howard, M. L., Van Dellen, A., Blakemore, C., Bartlett, P. F., & Hannan, A. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04365.x · Cited by 179
Maurer, D. (2012) · PubMed · Cited by 179
Increased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp, M. A., Schnaider-Beeri, M., Purohit, D. P., Perl, D. P., Haroutunian, V., & Sano, M. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31816029ec · Cited by 178
Longitudinal Psychiatric Symptoms in Prodromal Huntington’s Disease: A Decade of Data
Epping, E. A., Kim, J., Craufurd, D., Brashers-Krug, T. M., Anderson, K. E., McCusker, E. A., Luther, J., Long, J. D., Paulsen, J. S., & PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14121551 · Cited by 178
Zajac, M. S., Pang, T. Y. C., Wong, N., Weinrich, B., Leang, L. S. K., Craig, J. M., Saffery, R., & Hannan, A. J. (2010) · Hippocampus · doi:10.1002/hipo.20658 · Cited by 178
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease
Augood, S. J., Faull, R. L. M., & Emson, P. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420213 · Cited by 177
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174
Depression in classic versus akinetic‐rigid Parkinson's disease
Starkstein, S. E., Petracca, G., Chemerinski, E., Tesón, A., Sabe, L., Merello, M., & Leiguarda, R. (1998) · Movement Disorders · doi:10.1002/mds.870130109 · Cited by 174
Peng, Q., Masuda, N., Jiang, M., Li, Q., Zhao, M., Ross, C. A., & Duan, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.015 · Cited by 173
Van Raamsdonk, J. M., Pearson, J., Rogers, D. A., Bissada, N., Vogl, A. W., Hayden, M. R., & Leavitt, B. R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi147 · Cited by 173
Predictors, prodromes and incidence of postpartum depression
Chaudron, L. H., Klein, M. H., Remington, P., Palta, M., Allen, C., & Essex, M. J. (2001) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674820109049960 · Cited by 172
Boileau, I., Warsh, J. J., Guttman, M., Saint‐Cyr, J. A., McCluskey, T., Rusjan, P., Houle, S., Wilson, A. A., Meyer, J. H., & Kish, S. J. (2008) · Movement Disorders · doi:10.1002/mds.22212 · Cited by 171
Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
Ciammola, A., Sassone, J., Cannella, M., Calza, S., Poletti, B., Frati, L., Squitieri, F., & Silani, V. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30501 · Cited by 171
The role of dopamine in huntington's disease
Cepeda, C., Murphy, K. P. S., Parent, M., & Levine, M. S. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63425-2.00010-6 · Cited by 170
Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.003 · Cited by 168
Exercise and regulation of adipokine and myokine production
(2015) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2015.07.002 · Cited by 168
Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., Felice, F. G. D., & Ferreira, S. T. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.168 · Cited by 168
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
Gil, J. M. A. C., Mohapel, P., Araújo, I. M., Popovic, N., Li, J.-Y., Brundin, P., & Petersén, Å. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.006 · Cited by 167
Apostolova, L. G., & Thompson, P. M. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.10.026 · Cited by 166
Lai, J., Moxey, A., Nowak, G., Vashum, K., Bailey, K., & McEvoy, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.022 · Cited by 166
Pouladi, M. A., Graham, R. K., Karasinska, J. M., Xie, Y., Santos, R. D., Petersén, Å., & Hayden, M. R. (2008) · Brain · doi:10.1093/brain/awp006 · Cited by 166
Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management
Chi, S., Yu, J.-T., Tan, M.-S., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140324 · Cited by 165
Winter, C., von Rumohr, A., Mundt, A. P., Petrus, D. S., Klein, J., Lee, T., Morgenstern, R., Kupsch, A. R., & Juckel, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.002 · Cited by 162
Development of the HPA axis: Where and when do sex differences manifest?
Panagiotakopoulos, L., & Neigh, G. N. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.002 · Cited by 162
Depression in Parkinson's disease: clinical correlates and outcome
Rojo, A., Aguilar, M., Garolera, M., Cubo, E., Navas, I., & Quintana, S. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00067-1 · Cited by 161
Antunes, M. S., Goes, A. T. R., Boeira, S. P., Prigol, M., & Jesse, C. R. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.024 · Cited by 161
The Effects of a Multimodal Intervention on Outcomes of Persons With Early-Stage Dementia
Burgener, S. C., Yang, Y., Gilbert, R., & Marsh-Yant, S. (2008) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508317527 · Cited by 158
Wrann, C. D. (2015) · Brain Plasticity · doi:10.3233/bpl-150019 · Cited by 158
Insulin resistance and depression: cross sectional study
Timonen, M., Laakso, M., Jokelainen, J. J., Rajala, U., Meyer‐Rochow, V. B., & Keinanen-Kiukaanniemi, S. M. (2004) · BMJ · doi:10.1136/bmj.38313.513310.f71 · Cited by 157
Guanosine and its role in neuropathologies
Bettio, L. E. B., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9509-4 · Cited by 157
Self-citationPlasma inflammatory biomarkers for Huntington’s disease patients and mouse model
Chang, K., Wu, Y., Chen, Y., & Chen, C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.011 · Cited by 156
Gender and the Parkinson’s disease phenotype
Baba, Y., Putzke, J. D., Whaley, N. R., Wszołek, Z. K., & Uitti, R. J. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0835-7 · Cited by 155
Chiu, C., Liu, G., Leeds, P. R., & Chuang, D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.128 · Cited by 154
Microglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 154
Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume
van Mierlo, T., Chung, C., Foncke, E. M. J., Berendse, H. W., & van den Heuvel, O. A. (2015) · Movement Disorders · doi:10.1002/mds.26112 · Cited by 153
Monoamine metabolism in senile dementia of Alzheimer type
Cross, A. J., Crow, T. J., Johnson, J. A., Joseph, M. H., Perry, E. K., Perry, R. H., Blessed, G., & Tomlinson, B. E. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90149-1 · Cited by 153
Main, A. S. D., Gallo, J. J., & Pontone, G. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.020 · Cited by 151
Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis
Bomasang-Layno, E., Fadlon, I., Murray, A. N., & Himelhoch, S. S. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.018 · Cited by 150
Health‐related quality of life in Huntington's disease: Which factors matter most?
Ho, A. K., Gilbert, A. S., Mason, S., Goodman, A. O., & Barker, R. A. (2008) · Movement Disorders · doi:10.1002/mds.22412 · Cited by 150
Religa, P., Cao, R., Religa, D., Xue, Y., Bogdanović, N., Westaway, D. A., Marti, H. H., Winblad, B. G., & Cao, Y. (2013) · Scientific Reports · doi:10.1038/srep02053 · Cited by 150
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Jaunarajs, K. L. E., Angoa‐Pérez, M., Kuhn, D. M., & Bishop, C. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.007 · Cited by 149
Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Sanchez, M. G. D. B., Bourque, M., Morissette, M., & Paolo, T. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00163.x · Cited by 148
Thompson, S. J., Herrmann, N., Rapoport, M. J., & Lanctôt, K. L. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200407 · Cited by 147
Duan, W., Peng, Q., Masuda, N., Ford, E., Tryggestad, E. J., Ladenheim, B., Zhao, M., Cadet, J. L., Wong, J., & Ross, C. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.015 · Cited by 145
Major depressive disorder in Parkinson's disease: a register‐based study
Nilsson, F. M., Kessing, L. V., Sørensen, T. M., Andersen, P. K., & Bolwig, T. G. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02229.x · Cited by 145
Freude, S., Schilbach, K., & Schubert, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486527 · Cited by 144
Pouladi, M. A., Stanek, L. M., Xie, Y., Franciosi, S., Southwell, A. L., Deng, Y., Butland, S. L., Zhang, W., Cheng, S. H., Shihabuddin, L. S., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds037 · Cited by 144
Ledo, J. H., Azevedo, E. P., Beckman, D., Ribeiro, F. C., Santos, L. E., Razolli, D. S., Kincheski, G. C., Melo, H. M., Bellio, M., Teixeira, A. L., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1269-16.2016 · Cited by 144
Recent advances in treating Parkinson’s disease
Oertel, W. H. (2017) · F1000Research · doi:10.12688/f1000research.10100.1 · Cited by 144
Yau, S., Gil‐Mohapel, J., Christie, B. R., & So, K. (2014) · BioMed Research International · doi:10.1155/2014/403120 · Cited by 142
Self-citationCognitive impairments and depression in Parkinson's disease: a follow up study.
STARKSTEIN, S. E., BOLDUC, P. L., Mayberg, H. S., Preziosi, T. J., & Robinson, R. G. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.7.597 · Cited by 142
Impact of Gender Differences on the Outcome of Alzheimer’s Disease
Sinforiani, E., Citterio, A., Zucchella, C., Bono, G., Corbetta, S., Merlo, P., & Mauri, M. F. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318842 · Cited by 141
Bambico, F. R., Nguyen, N.-T., & Gobbi, G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.11.005 · Cited by 139
Björkqvist, M., Petersén, Å., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G. P., Tabrizi, S. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl094 · Cited by 138
Spuch, C., Antequera, D., Portero, A., Orive, G., Hernández, R. M., Molina, J. A., Bermejo‐Pareja, F., Pedraz, J. L., & Carro, E. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.042 · Cited by 136
Bode, F. J., Stephan, M., Suhling, H., Pabst, R., Straub, R. H., Raber, K. A., von Bonin, M., Nguyen, H. P., Rieß, O., Bauer, A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn159 · Cited by 136
Kehoe, P. G., Krawczak, M., Harper, P. S., Owen, M. J., & Jones, A. L. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.2.108 · Cited by 134
Risk of Parkinson disease after depression: A nationwide population-based study
Shen, C., Tsai, S., Perng, C., Kuo, B. I., & Yang, A. C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a956ad · Cited by 134
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
Troeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132
Zhao, L., Mao, Z., Woody, S. K., & Brinton, R. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.011 · Cited by 132
Depression and parkinson's disease: possible role of serotonergic mechanisms
Kostić, V., Djuričič, B., Čovičković-Šternić, N., Bumbaširević, L., Nikolić, M., & Mršulja, B. B. (1987) · Journal of Neurology · doi:10.1007/bf00314109 · Cited by 131
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea
Huot, P., Lévesque, M., & Parent, A. (2006) · Brain · doi:10.1093/brain/awl332 · Cited by 129
Cognitive and non‐cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease
Filali, M., Lalonde, R., & Rivest, S. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00453.x · Cited by 126
Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
Simpson, J. M., Gil‐Mohapel, J., Pouladi, M. A., Ghilan, M., Xie, Y., Hayden, M. R., & Christie, B. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.012 · Cited by 123
Self-citationMößner, R., Henneberg, A. E., Schmitt, A. G., Syagailo, Y. V., Grässle, M., Hennig, T., Simantov, R., Gerlach, M., Riederer, P. F., & Lesch, K. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000849 · Cited by 122
Hendricksen, M., Thomas, A. J., Ferrier, I. N., Ince, P., & O’Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1096 · Cited by 121
A quantitative investigation of the substantia nigra in Huntington's disease
Oyanagi, K., Takeda, S., Takahashi, H., Ohama, E., & Ikuta, F. (1989) · Annals of Neurology · doi:10.1002/ana.410260103 · Cited by 120
The influence of gender on phenotype and disease progression in patients with Huntington's disease
Zielonka, D., Marinus, J., Roos, R. A. C., Michele, G. D., Donato, S. D., Putter, H., Marcinkowski, T., Squitieri, F., Bentivoglio, A. R., & Landwehrmeyer, G. B. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.09.012 · Cited by 120
Chen, C., Eastwood, S. L., Hope, T., McDonald, B., Francis, P. T., & Esiri, M. M. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00254.x · Cited by 118
Menza, M. A., Palermo, B., Paola, R. D., Sage, J. I., & Ricketts, M. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200202 · Cited by 118
Niu, Y., Tan, J., Guan, J.-Q., Zhang, Z., & Wang, L. (2010) · Clinical Rehabilitation · doi:10.1177/0269215510376004 · Cited by 117
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
Tuon, T., Valvassori, S. S., Dal Pont, G. C., Paganini, C. S., Pozzi, B. G., Luciano, T. F., Souza, P. S., Quevedo, J., Souza, C. T., & Pinho, R. A. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.006 · Cited by 116
l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
Stansley, B. J., & Yamamoto, B. K. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.010 · Cited by 112
Epigenetic Regulation ofBDNFGene in Response to Stress
Fuchikami, M., Yamamoto, S., Morinobu, S., Takei, S., & Yamawaki, S. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.251 · Cited by 111
Nazarali, A. J., & Reynolds, G. P. (1992) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711237 · Cited by 111
Magnetic Resonance Imaging in Late-Life Depression: Multimodal Examination of Network Disruption
Sexton, C. E., Allan, C. L., Masurier, M. L., McDermott, L. M., Kalu, U. G., Herrmann, L. L., Mäurer, M. A., Bradley, K. M., Mackay, C. E., & Ebmeier, K. P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1862 · Cited by 111
Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study
Dobkin, R. D., Allen, L. A., & Menza, M. (2007) · Movement Disorders · doi:10.1002/mds.21455 · Cited by 107
Wang, P., Xie, Z., Guo, Y., Zhao, C., Jiang, H., Song, Y., Zhu, Z., Lai, C., Xu, S., & Bi, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.003 · Cited by 104
Picelli, A., Varalta, V., Melotti, C., Zatezalo, V., Fonte, C., Amato, S., Saltuari, L., Santamato, A., Fiore, P., & Smania, N. (2016) · Functional Neurology · doi:10.11138/fneur/2016.31.1.025 · Cited by 104
Anderson, G., Seo, M., Berk, M., Carvalho, A., & Maes, M. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160906161513 · Cited by 103
Goes, A. T. R., Souza, L. C., Filho, C. B., Fabbro, L. D., de Gomes, M. G., Boeira, S. P., & Jessé, C. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.042 · Cited by 103
Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons
Sawada, H., & Shimohama, S. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00059-7 · Cited by 103
Barbiero, J. K., Santiago, R. M., Tonin, F. S., Boschen, S. L., da Silva, L. M., Werner, M. F. D. P., Cunha, C. D., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.009 · Cited by 102
van Duijn, E., Kingma, E. M., Timman, R., Zitman, F. G., Tibben, A., Roos, R. A. C., & van der Mast, R. C. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1116 · Cited by 102
The role of oxidative stress in Huntington’s disease: Are antioxidants good therapeutic candidates?
Gil-Mohapel, J., Brocardo, P., & Christie, B. (2014) · Current Drug Targets · doi:10.2174/1389450115666140115113734 · Cited by 101
Self-citationDepression in the Early Stages of Huntington Disease
Epping, E. A., & Paulsen, J. S. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.45 · Cited by 101
Decreased striatal monoaminergic terminals in Huntington disease
Bohnen, N. I., Koeppe, R. A., Meyer, P., Ficaro, E. P., Wernette, K., Kilbourn, M. R., Kuhl, D. E., Frey, K. A., & Albin, R. L. (2000) · Neurology · doi:10.1212/wnl.54.9.1753 · Cited by 98
dos Santos, V. V., Santos, D. B., Lach, G., Rodrigues, A. L. S., Farina, M., de Lima, T. C. M., & Prediger, R. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.039 · Cited by 98
Self-citationIncreased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Reeves, S., Brown, R., Howard, R., & Grasby, P. (2009) · Neurology · doi:10.1212/01.wnl.0000341932.21961.f3 · Cited by 98
Hriţcu, L., Noumedem, J. A. K., Cioancă, O., Hăncianu, M., Postu, P. A., & Mihăşan, M. (2015) · Behavioral and Brain Functions · doi:10.1186/s12993-015-0059-7 · Cited by 98
Romano, A., Pace, L., Tempesta, B., Lavecchia, A. M., Macheda, T., Bedse, G., Petrella, A., Cifani, C., Serviddio, G., Vendemiale, G., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu020 · Cited by 98
Ugrumov, M. V. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.08.004 · Cited by 97
Suicidal ideation in a European Huntington's disease population
Hubers, A. A. M., van Duijn, E., Roos, R. A. C., Craufurd, D., Rickards, H. E., Landwehrmeyer, G. B., van der Mast, R. C., & Giltay, E. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.001 · Cited by 97
Depression in Alzheimer's Disease. Pathophysiology, Diagnosis, and Treatment
Modrego, P. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100153 · Cited by 97
Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression
Renoir, T., Zajac, M. S., Du, X., Pang, T. Y., Leang, L., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022133 · Cited by 96
Bassani, T. B., Gradowski, R. W., Zaminelli, T., Barbiero, J. K., Santiago, R. M., Boschen, S. L., Cunha, C. D., Lima, M. M. S., Andreatini, R., & Vital, M. A. B. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.068 · Cited by 95
Alterations in serum and brain trace element levels after antidepressant treatment: Part I. Zinc
Nowak, G., & Schlegel-Zawadzka, M. (1999) · Biological Trace Element Research · doi:10.1007/bf02784278 · Cited by 94
Resting-state fMRI study on drug-naive patients with Parkinson's disease and with depression
Luo, C., Chen, Q., Song, W., Chen, K., Guo, X., Yang, J., Huang, X., Gong, Q., & Shang, H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306237 · Cited by 94
Onset of action of antidepressants: results of different analyses
Thompson, C. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.386 · Cited by 92
Kajitani, N., Hisaoka‐Nakashima, K., Morioka, N., Okada‐Tsuchioka, M., Kaneko, M., Kasai, M., Shibasaki, C., Nakata, Y., & Takebayashi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051197 · Cited by 92
Sierksma, A. S. R., Prickaerts, J., Chouliaras, L., Rostamian, S., Delbroek, L., Rutten, B. P. F., Steinbusch, H. W. M., & van den Hove, D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.012 · Cited by 92
Wiener, C. D., Ferreira, S. D. M., Moreira, F. P., Bittencourt, G., de Oliveira, J. F., Molina, M. L., Jansen, K., Souza, L. D. D. M., Lara, D. R., Portela, L. V., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.067 · Cited by 90
de Castro, A. A., Ghisoni, K., Latini, A., Quevedo, J., Tasca, C. I., & Prediger, R. D. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.016 · Cited by 89
Ruan, Q., D’Onofrio, G., Sancarlo, D., Bao, Z., Greco, A., & Yu, Z. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0281-7 · Cited by 89
New insight into the therapeutic role of the serotonergic system in Parkinson's disease
Ohno, Y., Shimizu, S., Tokudome, K., Kunisawa, N., & Sasa, M. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.005 · Cited by 88
Santiago, R. M., Barbiero, J. K., Gradowski, R. W., Boschen, S. L., Lima, M. M. S., Cunha, C. D., Andreatini, R., & Vital, M. A. B. F. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.035 · Cited by 87
HPA Axis Dysregulation Associated to Apolipoprotein E4 Genotype in Alzheimer's Disease
Gil-Bea, F. J., Aisa, B., Solomon, A., Solas, M., Mugueta, C., Winblad, B. G., Kivipelto, M., Cedazo-Mínguez, Á., & Ramírez, M. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100663 · Cited by 86
Waeber, C., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90082-1 · Cited by 86
Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease
García-Alloza, M., Tsang, S. W. Y., Gil-Bea, F. J., Francis, P. T., Lai, M. K. P., Marcos, B., Chen, C., & Ramírez, M. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.003 · Cited by 86
Tanaka, Y. R., Meguro, K., Yamaguchi, S., Ishii, H., Watanuki, S., Funaki, Y., Yamaguchi, K., Yamadori, A., Iwata, R., & Itoh, M. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf03006670 · Cited by 86
Bradykinesia in early Huntington’s disease
Sánchez‐Pernaute, R., Künig, G., Alba, A. D. B., de Yébenes, J. G., Vontobel, P., & Leenders, K. L. (2000) · Neurology · doi:10.1212/wnl.54.1.119 · Cited by 85
Cioancă, O., Hriţcu, L., Mihăşan, M., Trifan, A., & Hăncianu, M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.021 · Cited by 84
Suzuki, M., Desmond, T. J., Albin, R. L., & Frey, K. A. (2001) · Synapse · doi:10.1002/syn.1089 · Cited by 84
Sacuiu, S. F., Insel, P. S., Mueller, S. G., Tosun, D., Mattsson, N., Jack, C. R., DeCarli, C. S., Petersen, R. C., Aisen, P. S. S., Weiner, M. W., et al. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.03.006 · Cited by 83
Lundh, S. H., Nilsson, N., Soylu-Kucharz, R., Kirik, D., & Petersén, Å. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt203 · Cited by 83
The genetic basis of Parkinson's disease
Foltynie, T., Sawcer, S., Brayne, C., & Barker, R. A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.4.363 · Cited by 80
Orvoën, S., Pla, P., Gardier, A. M., Saudou, F., & David, D. J. P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.063 · Cited by 80
Voorhees, J. R., Remy, M. T., Cintrón-Pérez, C. J., El Rassi, E., Khan, M. Z., Dutca, L. M., Yin, T. C., McDaniel, L. N., Williams, N. S., Brat, D. J., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.023 · Cited by 78
Cited by
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
Sipione, S., Monyror, J., Galleguillos, D., Steinberg, N., & Kadam, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.572965 · Cited by 325
Pitsillou, E., Bresnehan, S. M., Kagarakis, E. A., Wijoyo, S. J., Liang, J., Hung, A., & Karagiannis, T. C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-019-05129-3 · Cited by 206
Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment
Huang, Y.-Y., Gan, Y.-H., Yang, L., Cheng, W., & Yu, J.-T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.008 · Cited by 164
Hussain, M., Kumar, P., Khan, S., Gordon, D. K., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.11613 · Cited by 49
Li, X., Zhao, J., Li, Z., Zhang, L., & Huo, Z. (2020) · Neural Plasticity · doi:10.1155/2020/8850653 · Cited by 35
Metadata
- Authors
- Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 102
- Pages
- 56-84
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2937934820
- Cited by
- 269
- References
- 559
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.